Global 3D Medical and Surgical Imaging Platform Market
Report Scope:
The scope of this report is broad. It covers components, applications, end users and modes of deployment in 3D medical and surgical platforms. The market has been segmented by components into hardware, software and services. Revenue forecasts for 2018–2023 are given for each segment and regional market with estimated value derived from the revenue of manufacturers’ total revenues. The main geographic markets—North America, Europe, Asia Pacific and Rest of World (ROW) are included.
The report also includes a discussion of the major players across each region in the 3D medical and surgical imaging platforms market. Further, it explains the major drivers and regional dynamics of the global 3D medical and surgical imaging platforms market and current trends within the industry.
Key industry acquisitions and strategic alliances are given for the three-year period 2015–2018 (June).
This report also examines the main patent trends within the industry and profiles 25 market players that deal in 3D medical and surgical imaging platforms.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the main vendors in the global 3D medical and surgical imaging platforms market.
Report Includes:
The scope of this report is broad. It covers components, applications, end users and modes of deployment in 3D medical and surgical platforms. The market has been segmented by components into hardware, software and services. Revenue forecasts for 2018–2023 are given for each segment and regional market with estimated value derived from the revenue of manufacturers’ total revenues. The main geographic markets—North America, Europe, Asia Pacific and Rest of World (ROW) are included.
The report also includes a discussion of the major players across each region in the 3D medical and surgical imaging platforms market. Further, it explains the major drivers and regional dynamics of the global 3D medical and surgical imaging platforms market and current trends within the industry.
Key industry acquisitions and strategic alliances are given for the three-year period 2015–2018 (June).
This report also examines the main patent trends within the industry and profiles 25 market players that deal in 3D medical and surgical imaging platforms.
The report concludes with a special focus on the vendor landscape and includes detailed profiles of the main vendors in the global 3D medical and surgical imaging platforms market.
Report Includes:
- 151 data tables and 66 additional tables
- An overview of the global 3D medical and surgical imaging platform market
- Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Characterization and quantification of the market potential for 3D medical and surgical imaging platform by geographical regions, components, applications, end users and mode of deployment
- Discussion of major drivers, technological advancements and regional dynamics of the global 3D medical and surgical imaging platform market, and current trends within the industry
- Assessment of the vendor landscape and detailed profiles of the major vendors in the global 3D medical and surgical imaging platform market
- Company profiles of major players in the market, including Ambra Health, Esaote Spa, GE Healthcare, Koninklijke Philips NV, Medtronic Inc., Siemens Healthcare, Stryker Corp. and Whiteclouds
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Introduction
Report Scope
Regulations
United States
European Union
Australia
China
Japan
ASEAN
South Africa
Investment Analysis
3D MEDICAL AND SURGICAL IMAGING PLATFORMS BY COMPONENT
Hardware
Software
Services
3D MEDICAL AND SURGICAL IMAGING PLATFORMS BY APPLICATION
Ultrasound
Digital Radiography
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Nuclear Imaging
Mammography
3D MEDICAL AND SURGICAL IMAGING PLATFORMS BY DEPLOYMENT
On-premise-based Platform
Cloud-based Platform
Web-based Platform
3D MEDICAL AND SURGICAL IMAGING PLATFORM BY END USER
Hospitals
Ambulatory and Healthcare Settings
Diagnostic Centers
Research Centers
Industry Growth Drivers
Development of Modern Visualization Methods and Technology Platforms
High Adoption of Minimally Invasive Procedures
Adoption of Hybrid Operating Rooms as Part of an Efficient Medical Infrastructure
Increasing Use of Automation Technologies in the Healthcare Sector
Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
New Innovative Solutions by Platform Providers in the Market
Increasing Aging Population
Increased Prevalence of Chronic Diseases
Rising Healthcare Expenditures
CHAPTER 4 MARKET BREAKDOWN BY COMPONENT
Hardware
Software
Services
CHAPTER 5 MARKET BREAKDOWN BY APPLICATION
Ultrasound
3D ULTRASOUND SCANNING TECHNIQUES
Increasing Incidence of Infectious and Chronic Diseases Drives the Ultrasound Market
Research and Development in CVD
Digital Radiography
Advantages of X-Ray Machines
Magnetic Resonance Imaging
Advancements in 3D Imaging
Computed Tomography
3D SURGICAL AND MEDICAL IMAGING PLATFORMS FOR CT SCAN
Common Applications of CT Scans
Application of CT in Pediatric Patients
Benefits
Advancements in Imaging Systems
Nuclear Imaging
Market Drivers
Positron Emission Computed Tomography (PET) Imaging
Single Photon Emission Computed Tomography (SPECT) Imaging
Scintigraphy Imaging
Estimation of Disability-Adjusted Life Years (DALYs) for Neurological Diseases
Technological Advancements in Nuclear Imaging:
Mammography
Endoscopy
Advantages of 3D Endoscopy System
Types
Innovation and New Products
Others (Laparoscopy, X-ray, etc.)
Advancements in Laparoscopy
CHAPTER 6 MARKET BREAKDOWN BY TYPE OF DEPLOYMENT
On-premise-based Platforms
Cloud-based Platform
Benefits
Drawbacks
Web-based Platform
Benefits
Drawbacks
CHAPTER 7 MARKET BREAKDOWN BY END USER
Hospitals
According to Breast Cancer (Australia)
Cancer Research U.K. Statistics
Increased Number of Hospitals Worldwide
Increasing Prevalence of Cardiovascular Diseases
Hybrid Operating Room
Patient-Centric Trend
Ambulatory and Healthcare Settings
Diagnostic Centers
Technological Advancements in 3D Medical and Surgical Imaging Platforms
Increasing Healthcare Expenditure
Research Centers
CHAPTER 8 MARKET BACKGROUND BY REGION
North America
United States
Canada
Mexico
Europe
United Kingdom
France
Germany
Spain
Italy
Rest of Europe (ROE)
Asia Pacific
China
India
Japan
Australia
Rest of Asia Pacific
Rest of the World (ROW)
Latin America
Middle East and Africa (MEA)
CHAPTER 9 INDUSTRY STRUCTURE
Innovations within the Industry
Supply Chain Analysis
Suppliers
Research and Development (R&D)
Manufacturing
Distribution
End Users
Opportunities in Supply Chain
Artificial Intelligence and Analytics
Block-Chain and Internet of Things (IoT)
Robotics
CHAPTER 10 COMPANY PROFILES
AMBRA HEALTH
ARTERYS
BRAINLAB AG
CANON MEDICAL SYSTEMS LTD. (ACQUIRED TOSHIBA CORP.)
DEPUY SYNTHES
ESAOTE SPA
FOVIA
GE HEALTHCARE
KITWARE INC.
KONINKLIJKE PHILIPS NV
LEXMARK INTERNATIONAL INC.
MACH7 TECHNOLOGIES LTD.
MCKESSON CORP.
MEDTRONIC INC.
NAVEGATIUM
NDS SURGICAL IMAGING LLC
NERVEVISION INC.
OLYMPUS CORP.
PIE MEDICAL IMAGING BV
PLANMECA OY
QUIBIM SL
SIEMENS HEALTHCARE
STRYKER CORP.
SURGICAL THEATER LLC
WHITECLOUDS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Introduction
Report Scope
Regulations
United States
European Union
Australia
China
Japan
ASEAN
South Africa
Investment Analysis
3D MEDICAL AND SURGICAL IMAGING PLATFORMS BY COMPONENT
Hardware
Software
Services
3D MEDICAL AND SURGICAL IMAGING PLATFORMS BY APPLICATION
Ultrasound
Digital Radiography
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Nuclear Imaging
Mammography
3D MEDICAL AND SURGICAL IMAGING PLATFORMS BY DEPLOYMENT
On-premise-based Platform
Cloud-based Platform
Web-based Platform
3D MEDICAL AND SURGICAL IMAGING PLATFORM BY END USER
Hospitals
Ambulatory and Healthcare Settings
Diagnostic Centers
Research Centers
Industry Growth Drivers
Development of Modern Visualization Methods and Technology Platforms
High Adoption of Minimally Invasive Procedures
Adoption of Hybrid Operating Rooms as Part of an Efficient Medical Infrastructure
Increasing Use of Automation Technologies in the Healthcare Sector
Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
New Innovative Solutions by Platform Providers in the Market
Increasing Aging Population
Increased Prevalence of Chronic Diseases
Rising Healthcare Expenditures
CHAPTER 4 MARKET BREAKDOWN BY COMPONENT
Hardware
Software
Services
CHAPTER 5 MARKET BREAKDOWN BY APPLICATION
Ultrasound
3D ULTRASOUND SCANNING TECHNIQUES
Increasing Incidence of Infectious and Chronic Diseases Drives the Ultrasound Market
Research and Development in CVD
Digital Radiography
Advantages of X-Ray Machines
Magnetic Resonance Imaging
Advancements in 3D Imaging
Computed Tomography
3D SURGICAL AND MEDICAL IMAGING PLATFORMS FOR CT SCAN
Common Applications of CT Scans
Application of CT in Pediatric Patients
Benefits
Advancements in Imaging Systems
Nuclear Imaging
Market Drivers
Positron Emission Computed Tomography (PET) Imaging
Single Photon Emission Computed Tomography (SPECT) Imaging
Scintigraphy Imaging
Estimation of Disability-Adjusted Life Years (DALYs) for Neurological Diseases
Technological Advancements in Nuclear Imaging:
Mammography
Endoscopy
Advantages of 3D Endoscopy System
Types
Innovation and New Products
Others (Laparoscopy, X-ray, etc.)
Advancements in Laparoscopy
CHAPTER 6 MARKET BREAKDOWN BY TYPE OF DEPLOYMENT
On-premise-based Platforms
Cloud-based Platform
Benefits
Drawbacks
Web-based Platform
Benefits
Drawbacks
CHAPTER 7 MARKET BREAKDOWN BY END USER
Hospitals
According to Breast Cancer (Australia)
Cancer Research U.K. Statistics
Increased Number of Hospitals Worldwide
Increasing Prevalence of Cardiovascular Diseases
Hybrid Operating Room
Patient-Centric Trend
Ambulatory and Healthcare Settings
Diagnostic Centers
Technological Advancements in 3D Medical and Surgical Imaging Platforms
Increasing Healthcare Expenditure
Research Centers
CHAPTER 8 MARKET BACKGROUND BY REGION
North America
United States
Canada
Mexico
Europe
United Kingdom
France
Germany
Spain
Italy
Rest of Europe (ROE)
Asia Pacific
China
India
Japan
Australia
Rest of Asia Pacific
Rest of the World (ROW)
Latin America
Middle East and Africa (MEA)
CHAPTER 9 INDUSTRY STRUCTURE
Innovations within the Industry
Supply Chain Analysis
Suppliers
Research and Development (R&D)
Manufacturing
Distribution
End Users
Opportunities in Supply Chain
Artificial Intelligence and Analytics
Block-Chain and Internet of Things (IoT)
Robotics
CHAPTER 10 COMPANY PROFILES
AMBRA HEALTH
ARTERYS
BRAINLAB AG
CANON MEDICAL SYSTEMS LTD. (ACQUIRED TOSHIBA CORP.)
DEPUY SYNTHES
ESAOTE SPA
FOVIA
GE HEALTHCARE
KITWARE INC.
KONINKLIJKE PHILIPS NV
LEXMARK INTERNATIONAL INC.
MACH7 TECHNOLOGIES LTD.
MCKESSON CORP.
MEDTRONIC INC.
NAVEGATIUM
NDS SURGICAL IMAGING LLC
NERVEVISION INC.
OLYMPUS CORP.
PIE MEDICAL IMAGING BV
PLANMECA OY
QUIBIM SL
SIEMENS HEALTHCARE
STRYKER CORP.
SURGICAL THEATER LLC
WHITECLOUDS
LIST OF TABLES
Summary Table: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 1: Report Scope
Table 2: Examples of Medical Software Under the European Union
Table 3: Medical Software Regulations
Table 4: Investments in 3D Medical and Surgical Imaging
Table 5: Common Robot-Assisted, Minimally Invasive Surgeries
Table 6: Common (Non-robot) Assisted Minimally Invasive Surgeries
Table 7: Benefits of 3D Imaging Techniques for Patient and Physicians
Table 8: Global Geriatric Population (60 Years+), by Region, 2015-2050
Table 9: 10 Leading Causes of Burden of Disease Worldwide, 2004 vs. 2030
Table 10: Key Investments in Medical Imaging Systems and Technologies Since 2015
Table 11: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 12: Comparison of the Configurations of Preamplifiers Used in Imagers
Table 13: Global Market for 3D Medical and Surgical Imaging Platform Hardware, by Region, Through 2023
Table 14: Global Deaths from Cancer, 2015 and 2030
Table 15: Global Deaths from CVD, 2015 and 2030
Table 16: Global CVD Deaths, 2015
Table 17: Global Market for 3D Medical and Surgical Imaging Platform Software, by Region, Through 2023
Table 18: 3D Medical and Surgical Imaging Services
Table 19: Global Market for 3D Medical and Surgical Imaging Platform Services, by Region, Through 2023
Table 20: Global Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 21: Some Major Uses of Ultrasound
Table 22: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Ultrasound Systems, by Region, Through 2023
Table 23: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Digital Radiography, by Region, Through 2023
Table 24: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
Table 25: Oral Cavity and Pharynx Cancer as a Percentage of All New Cancer Cases in the U.S., 2018
Table 26: New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
Table 27: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in MRI Systems, by Region, Through 2023
Table 28: Global Number of Deaths Caused by Selected Chronic Diseases, 2015
Table 29: Rising Chronic Diseases in the United States, 2000-2030
Table 30: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Computed Tomography Systems, by Region, Through 2023
Table 31: Top 10 Causes of Death, 2016
Table 32: Percentage of Global Population with Cancer, 2005-2016
Table 33: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging Systems, by Region, Through 2023
Table 34: Number of DALYs for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 and 2030
Table 35: Deaths Attributable to Neurological Disorders, 2005, 2015 and 2030
Table 36: YLDs Associated with Neurological Disorders and Other Diseases and Injuries with Neurological Sequelae Projected for 2005, 2015 and 2030
Table 37: Global Market for the Application of 3D Medical and Surgical Imaging Platforms Mammography Systems, by Region, Through 2023
Table 38: Recent Strategic Initiatives of Key Market Players
Table 39: Age-Specific Probabilities of Developing Invasive Female Breast Cancer, 2013-2023
Table 40: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
Table 41: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
Table 42: Comparison of Endoscopic Systems
Table 43: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Endoscopy, by Region, Through 2023
Table 44: Global Disease Burden Rates, by Cancer Type, 2016
Table 45: Global Market for 3D Medical and Surgical Imaging Platforms in Other Applications, by Region, Through 2023
Table 46: Advantages of Laparoscopic Surgery over Conventional Open Surgery
Table 47: Benefits and Drawbacks of On-premise, Cloud-based and Web-based Platforms
Table 48: Global Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 49: Global Market for On-premise 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 50: Companies That Offer Novel On-premise 3D Medical and Surgical Imaging Platforms with Features
Table 51: Benefits and Drawbacks of On-premise 3D Medical and Surgical Imaging Platforms
Table 52: Benefits and Drawbacks of Cloud-Based 3D Medical and Surgical Imaging Platforms
Table 53: Companies That Offer Cloud-based 3D Medical and Surgical Imaging Platforms with Features
Table 54: Global Market for Cloud-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 55: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
Table 56: Benefits and Drawbacks of Web-based 3D Medical and Surgical Imaging Platforms
Table 57: Companies That Offer Web-based 3D Medical and Surgical Imaging Platforms with Features
Table 58: Global Market for Web-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 59: Global Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 60: Global Market for 3D Medical and Surgical Imaging Platforms in Hospitals, by Region, Through 2023
Table 61: Most Common Cancers Causing Death Globally, by Type, 2015
Table 62: Estimated Female Breast Cancer Deaths in the U.S., by Age, 2017
Table 63: U.S. Hospitals, by Type, 2016
Table 64: Global Prevalence of Dementia, 2015-2050
Table 65: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
Table 66: Global Market for 3D Medical and Surgical Imaging Platforms in Ambulatory Healthcare Settings, by Region, Through 2023
Table 67: Global Market for 3D Medical and Surgical Imaging Platforms in Diagnostic Centers, by Region, Through 2023
Table 68: Technological Advancements, 2015-2018
Table 69: Advanced Product Development, 2015 and 2018
Table 70: Global Healthcare Expenditure, 2012 and 2015
Table 71: Distribution of Healthcare Expenditures, by Country, 2017
Table 72: Alzheimer’s Dementia in the United States, by Age Group, 2017
Table 73: Global Causes of Mortality, by Gender, 2015 (or Nearest Year)
Table 74: Global Market for 3D Medical and Surgical Imaging Platform in Research Centers, by Region, Through 2023
Table 75: Estimated U.S. Medical and Health Research Expenditures, Federal Government Agencies, 2014 and 2015
Table 76: R&D Expenditures, by Selected Scientific Agencies, 2015
Table 77: German Government R&D Spending, by Research Area, 2016 and 2017
Table 78: North American Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 79: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 80: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Deployment, Through 2023
Table 81: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 82: U.S. Estimated New Cancer Cases (Males), by Type, 2017
Table 83: U.S. Estimated New Cancer Cases (Females), by Type, 2017
Table 84: 10 Most Common Chronic Conditions for Adults 65+
Table 85: Chronic Disease, 2005–2030
Table 86: U.S. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 87: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 88: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 89: New Cancer Cases and Estimated Deaths in Canada, 2016
Table 90: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 91: Canadian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 92: Total Healthcare Expenditure in Europe, by Category, 2018
Table 93: European Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 94: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 95: Deaths from CVD and Number of People Living with CVD in the United Kingdom, 2015-2017
Table 96: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 97: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 98: U.K. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 99: French Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 100: Musculoskeletal Disorders in France, by Variable Type, 2016
Table 101: French Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 102: French Health Spending and Financing, 2005–2015
Table 103: French Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 104: French Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 105: Frequency of Cardiac Procedures in Germany, 2016
Table 106: German Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 107: Geriatric Population in Germany, 2015-2030
Table 108: German Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 109: German Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 110: German Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 111: Hospitals in Germany, by Category, 2015 and 2016
Table 112: Estimates of Cancer Incidence in Spain, by Type of Cancer, 2015
Table 113: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 114: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 115: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 116: Spanish Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 117: ROE Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 118: ROE Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 119: ROE Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 120: ROE Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 121: Breast Cancer in Norway, 2014 and 2015
Table 122: Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 123: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 124: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 125: Chinese Cancer Prevalence, by Gender and Type, 2016
Table 126: Current Chinese Cancer Grants, by Gender and Cancer Type, 2017
Table 127: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 128: Healthcare Facilities in China, as of October 2016
Table 129: Chinese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 130: Indian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 131: Diagnostics Imaging Investments in India, 2016
Table 132: Indian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 133: Indian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 134: Number of Aesthetic Surgical Procedures Performed in India, 2016
Table 135: Indian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 136: Japanese Aging Population and Future Estimates, 2010-2040
Table 137: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 138: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 139: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 140: Japanese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 141: Australian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 142: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
Table 143: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
Table 144: 10 Most Common Causes of Death from Cancer in Australia (Male), 2017
Table 145: 10 Most Common Causes of Death from Cancer in Australia (Females), 2017
Table 146: Australian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 147: Australian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 148: Australian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 149: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 150: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 151: Medical Tourism Revenue, Malaysia, 2011-2016
Table 152: Foreign Patients, Malaysia, 2011-2016
Table 153: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 154: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 155: Rest of the World Market for 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 156: ROW 60+ Population, by Region
Table 157: New Cases of Cancer, by Gender in Brazil, 2016
Table 158: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 159: 60+ Population in Brazil, 2015-2050
Table 160: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 161: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 162: Projected Healthcare Spending in Argentina, 2014 and 2040
Table 163: Leading Causes of Death in Argentina and Percentage Change between 2005 and 2016
Table 164: Latin American Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 165: MEA Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 166: Department of Health, Abu Dhabi Cancer Screening Recommendations
Table 167: MEA 3D Market for Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 168: MEA Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 169: MEA Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 170: Innovations within the Industry
Table 171: 3D Medical and Surgical Imaging Instruments and Their Components
Table 172: Mandatory Regulatory Guidelines for Suppliers and Manufacturers
Table 173: Suppliers and Manufacturers for 3D Medical and Surgical Imaging Devices in the U.S.
Table 174: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in China
Table 175: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in the Rest of Asia-Pacific
Table 176: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in Europe
Table 177: Ambra Health: Product Portfolio
Table 178: Ambra Health: Recent Developments, 2018
Table 179: Arterys: Product Portfolio
Table 180: Arterys: Recent Developments, 2018
Table 181: Brainlab AG: Product Portfolio
Table 182: Canon Medical Systems Ltd.: Product Portfolio
Table 183: Canon Medical Systems Ltd.: Recent Development, 2018
Table 184: DePuy Synthes: Product Portfolio
Table 185: Esaote SpA: Product Portfolio
Table 186: Esaote SpA: Recent Development, 2017
Table 187: Fovia: Product Portfolio
Table 188: Fovia: Recent Developments, 2015-2017
Table 189: GE Healthcare: Product Portfolio
Table 190: GE Healthcare: Recent Developments, 2015-2017
Table 191: Kitware Inc.: Product Portfolio
Table 192: Koninklijke Philips NV: Product Portfolio
Table 193: Koninklijke Philips NV: Recent Development 2017 and 2018
Table 194: Lexmark International Inc.: Product Portfolio
Table 195: Mach7 Technologies Ltd.: Product Portfolio
Table 196: Mach7 Technologies Ltd.: Recent Developments, 2016 and 2017
Table 197: McKesson Corp.: Product Portfolio
Table 198: Medtronic Inc.: Product Portfolio
Table 199: Medtronic Inc.: Recent Developments 2015-2018
Table 200: Navegatium: Product Portfolio
Table 201: NDS Surgical Imaging LLC: Product Portfolio
Table 202: NerveVision Inc.: Product Portfolio
Table 203: Olympus Corp.: Product Portfolio
Table 204: Olympus Corp.: Recent Developments, 2017
Table 205: PIE Medical Imaging BV: Product Portfolio
Table 206: PIE Medical Imaging BV: Recent Developments, 2017 and 2018
Table 207: Planmeca OY: Product Portfolio
Table 208: Quibim SL: Product Portfolio
Table 209: Siemens Healthcare: Product Portfolio
Table 210: Siemens Healthcare: Recent Developments, 2017
Table 211: Stryker Corp.: Product Portfolio
Table 212: Stryker Corp.: Recent Developments, 2015
Table 213: Surgical Theater LLC: Product Portfolio
Table 214: Surgical Theater LLC: Recent Development, 2015
Table 215: WhiteClouds: Product Portfolio
Table 216: WhiteClouds: Recent Developments, 2016
Summary Table: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 1: Report Scope
Table 2: Examples of Medical Software Under the European Union
Table 3: Medical Software Regulations
Table 4: Investments in 3D Medical and Surgical Imaging
Table 5: Common Robot-Assisted, Minimally Invasive Surgeries
Table 6: Common (Non-robot) Assisted Minimally Invasive Surgeries
Table 7: Benefits of 3D Imaging Techniques for Patient and Physicians
Table 8: Global Geriatric Population (60 Years+), by Region, 2015-2050
Table 9: 10 Leading Causes of Burden of Disease Worldwide, 2004 vs. 2030
Table 10: Key Investments in Medical Imaging Systems and Technologies Since 2015
Table 11: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 12: Comparison of the Configurations of Preamplifiers Used in Imagers
Table 13: Global Market for 3D Medical and Surgical Imaging Platform Hardware, by Region, Through 2023
Table 14: Global Deaths from Cancer, 2015 and 2030
Table 15: Global Deaths from CVD, 2015 and 2030
Table 16: Global CVD Deaths, 2015
Table 17: Global Market for 3D Medical and Surgical Imaging Platform Software, by Region, Through 2023
Table 18: 3D Medical and Surgical Imaging Services
Table 19: Global Market for 3D Medical and Surgical Imaging Platform Services, by Region, Through 2023
Table 20: Global Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 21: Some Major Uses of Ultrasound
Table 22: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Ultrasound Systems, by Region, Through 2023
Table 23: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Digital Radiography, by Region, Through 2023
Table 24: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
Table 25: Oral Cavity and Pharynx Cancer as a Percentage of All New Cancer Cases in the U.S., 2018
Table 26: New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
Table 27: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in MRI Systems, by Region, Through 2023
Table 28: Global Number of Deaths Caused by Selected Chronic Diseases, 2015
Table 29: Rising Chronic Diseases in the United States, 2000-2030
Table 30: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Computed Tomography Systems, by Region, Through 2023
Table 31: Top 10 Causes of Death, 2016
Table 32: Percentage of Global Population with Cancer, 2005-2016
Table 33: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging Systems, by Region, Through 2023
Table 34: Number of DALYs for Neurological Disorders and as Percentage of Global DALYs Projected for 2005, 2015 and 2030
Table 35: Deaths Attributable to Neurological Disorders, 2005, 2015 and 2030
Table 36: YLDs Associated with Neurological Disorders and Other Diseases and Injuries with Neurological Sequelae Projected for 2005, 2015 and 2030
Table 37: Global Market for the Application of 3D Medical and Surgical Imaging Platforms Mammography Systems, by Region, Through 2023
Table 38: Recent Strategic Initiatives of Key Market Players
Table 39: Age-Specific Probabilities of Developing Invasive Female Breast Cancer, 2013-2023
Table 40: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
Table 41: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
Table 42: Comparison of Endoscopic Systems
Table 43: Global Market for the Application of 3D Medical and Surgical Imaging Platforms in Endoscopy, by Region, Through 2023
Table 44: Global Disease Burden Rates, by Cancer Type, 2016
Table 45: Global Market for 3D Medical and Surgical Imaging Platforms in Other Applications, by Region, Through 2023
Table 46: Advantages of Laparoscopic Surgery over Conventional Open Surgery
Table 47: Benefits and Drawbacks of On-premise, Cloud-based and Web-based Platforms
Table 48: Global Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 49: Global Market for On-premise 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 50: Companies That Offer Novel On-premise 3D Medical and Surgical Imaging Platforms with Features
Table 51: Benefits and Drawbacks of On-premise 3D Medical and Surgical Imaging Platforms
Table 52: Benefits and Drawbacks of Cloud-Based 3D Medical and Surgical Imaging Platforms
Table 53: Companies That Offer Cloud-based 3D Medical and Surgical Imaging Platforms with Features
Table 54: Global Market for Cloud-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 55: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
Table 56: Benefits and Drawbacks of Web-based 3D Medical and Surgical Imaging Platforms
Table 57: Companies That Offer Web-based 3D Medical and Surgical Imaging Platforms with Features
Table 58: Global Market for Web-based 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 59: Global Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 60: Global Market for 3D Medical and Surgical Imaging Platforms in Hospitals, by Region, Through 2023
Table 61: Most Common Cancers Causing Death Globally, by Type, 2015
Table 62: Estimated Female Breast Cancer Deaths in the U.S., by Age, 2017
Table 63: U.S. Hospitals, by Type, 2016
Table 64: Global Prevalence of Dementia, 2015-2050
Table 65: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
Table 66: Global Market for 3D Medical and Surgical Imaging Platforms in Ambulatory Healthcare Settings, by Region, Through 2023
Table 67: Global Market for 3D Medical and Surgical Imaging Platforms in Diagnostic Centers, by Region, Through 2023
Table 68: Technological Advancements, 2015-2018
Table 69: Advanced Product Development, 2015 and 2018
Table 70: Global Healthcare Expenditure, 2012 and 2015
Table 71: Distribution of Healthcare Expenditures, by Country, 2017
Table 72: Alzheimer’s Dementia in the United States, by Age Group, 2017
Table 73: Global Causes of Mortality, by Gender, 2015 (or Nearest Year)
Table 74: Global Market for 3D Medical and Surgical Imaging Platform in Research Centers, by Region, Through 2023
Table 75: Estimated U.S. Medical and Health Research Expenditures, Federal Government Agencies, 2014 and 2015
Table 76: R&D Expenditures, by Selected Scientific Agencies, 2015
Table 77: German Government R&D Spending, by Research Area, 2016 and 2017
Table 78: North American Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 79: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 80: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Deployment, Through 2023
Table 81: U.S. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 82: U.S. Estimated New Cancer Cases (Males), by Type, 2017
Table 83: U.S. Estimated New Cancer Cases (Females), by Type, 2017
Table 84: 10 Most Common Chronic Conditions for Adults 65+
Table 85: Chronic Disease, 2005–2030
Table 86: U.S. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 87: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 88: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 89: New Cancer Cases and Estimated Deaths in Canada, 2016
Table 90: Canadian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 91: Canadian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 92: Total Healthcare Expenditure in Europe, by Category, 2018
Table 93: European Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 94: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 95: Deaths from CVD and Number of People Living with CVD in the United Kingdom, 2015-2017
Table 96: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 97: U.K. Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 98: U.K. Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 99: French Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 100: Musculoskeletal Disorders in France, by Variable Type, 2016
Table 101: French Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 102: French Health Spending and Financing, 2005–2015
Table 103: French Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 104: French Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 105: Frequency of Cardiac Procedures in Germany, 2016
Table 106: German Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 107: Geriatric Population in Germany, 2015-2030
Table 108: German Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 109: German Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 110: German Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 111: Hospitals in Germany, by Category, 2015 and 2016
Table 112: Estimates of Cancer Incidence in Spain, by Type of Cancer, 2015
Table 113: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 114: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 115: Spanish Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 116: Spanish Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 117: ROE Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 118: ROE Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 119: ROE Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 120: ROE Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 121: Breast Cancer in Norway, 2014 and 2015
Table 122: Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Country, Through 2023
Table 123: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 124: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 125: Chinese Cancer Prevalence, by Gender and Type, 2016
Table 126: Current Chinese Cancer Grants, by Gender and Cancer Type, 2017
Table 127: Chinese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 128: Healthcare Facilities in China, as of October 2016
Table 129: Chinese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 130: Indian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 131: Diagnostics Imaging Investments in India, 2016
Table 132: Indian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 133: Indian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 134: Number of Aesthetic Surgical Procedures Performed in India, 2016
Table 135: Indian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 136: Japanese Aging Population and Future Estimates, 2010-2040
Table 137: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 138: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 139: Japanese Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 140: Japanese Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 141: Australian Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 142: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
Table 143: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
Table 144: 10 Most Common Causes of Death from Cancer in Australia (Male), 2017
Table 145: 10 Most Common Causes of Death from Cancer in Australia (Females), 2017
Table 146: Australian Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 147: Australian Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 148: Australian Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 149: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 150: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 151: Medical Tourism Revenue, Malaysia, 2011-2016
Table 152: Foreign Patients, Malaysia, 2011-2016
Table 153: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 154: Rest of Asia Pacific Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 155: Rest of the World Market for 3D Medical and Surgical Imaging Platforms, by Region, Through 2023
Table 156: ROW 60+ Population, by Region
Table 157: New Cases of Cancer, by Gender in Brazil, 2016
Table 158: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 159: 60+ Population in Brazil, 2015-2050
Table 160: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 161: Latin American Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 162: Projected Healthcare Spending in Argentina, 2014 and 2040
Table 163: Leading Causes of Death in Argentina and Percentage Change between 2005 and 2016
Table 164: Latin American Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 165: MEA Market for 3D Medical and Surgical Imaging Platforms, by Component, Through 2023
Table 166: Department of Health, Abu Dhabi Cancer Screening Recommendations
Table 167: MEA 3D Market for Medical and Surgical Imaging Platforms, by Type of Deployment, Through 2023
Table 168: MEA Market for 3D Medical and Surgical Imaging Platforms, by Application, Through 2023
Table 169: MEA Market for 3D Medical and Surgical Imaging Platforms, by End User, Through 2023
Table 170: Innovations within the Industry
Table 171: 3D Medical and Surgical Imaging Instruments and Their Components
Table 172: Mandatory Regulatory Guidelines for Suppliers and Manufacturers
Table 173: Suppliers and Manufacturers for 3D Medical and Surgical Imaging Devices in the U.S.
Table 174: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in China
Table 175: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in the Rest of Asia-Pacific
Table 176: Suppliers and Manufacturers of 3D Medical and Surgical Imaging Devices in Europe
Table 177: Ambra Health: Product Portfolio
Table 178: Ambra Health: Recent Developments, 2018
Table 179: Arterys: Product Portfolio
Table 180: Arterys: Recent Developments, 2018
Table 181: Brainlab AG: Product Portfolio
Table 182: Canon Medical Systems Ltd.: Product Portfolio
Table 183: Canon Medical Systems Ltd.: Recent Development, 2018
Table 184: DePuy Synthes: Product Portfolio
Table 185: Esaote SpA: Product Portfolio
Table 186: Esaote SpA: Recent Development, 2017
Table 187: Fovia: Product Portfolio
Table 188: Fovia: Recent Developments, 2015-2017
Table 189: GE Healthcare: Product Portfolio
Table 190: GE Healthcare: Recent Developments, 2015-2017
Table 191: Kitware Inc.: Product Portfolio
Table 192: Koninklijke Philips NV: Product Portfolio
Table 193: Koninklijke Philips NV: Recent Development 2017 and 2018
Table 194: Lexmark International Inc.: Product Portfolio
Table 195: Mach7 Technologies Ltd.: Product Portfolio
Table 196: Mach7 Technologies Ltd.: Recent Developments, 2016 and 2017
Table 197: McKesson Corp.: Product Portfolio
Table 198: Medtronic Inc.: Product Portfolio
Table 199: Medtronic Inc.: Recent Developments 2015-2018
Table 200: Navegatium: Product Portfolio
Table 201: NDS Surgical Imaging LLC: Product Portfolio
Table 202: NerveVision Inc.: Product Portfolio
Table 203: Olympus Corp.: Product Portfolio
Table 204: Olympus Corp.: Recent Developments, 2017
Table 205: PIE Medical Imaging BV: Product Portfolio
Table 206: PIE Medical Imaging BV: Recent Developments, 2017 and 2018
Table 207: Planmeca OY: Product Portfolio
Table 208: Quibim SL: Product Portfolio
Table 209: Siemens Healthcare: Product Portfolio
Table 210: Siemens Healthcare: Recent Developments, 2017
Table 211: Stryker Corp.: Product Portfolio
Table 212: Stryker Corp.: Recent Developments, 2015
Table 213: Surgical Theater LLC: Product Portfolio
Table 214: Surgical Theater LLC: Recent Development, 2015
Table 215: WhiteClouds: Product Portfolio
Table 216: WhiteClouds: Recent Developments, 2016
LIST OF FIGURES
Summary Figure: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, 2017-2023
Figure 1: Annual Market Revenues for Robot-Assisted, Minimally Invasive Surgery, 2015-2025
Figure 2: Annual Market Revenues from Sales of Endoscopy Devices, 2015-2024
Figure 3: Cost Breakdown: Owning Hybrid Operating Rooms, by Equipment Type
Figure 4: Cloud Computing in Medical and Surgical Imaging
Figure 5: Trends in Rising Aged Population Around the World, 2014-2022
Figure 6: Trends in Number of Deaths Due to Chronic Diseases, 2005-2020
Figure 7: Rising Trends in Healthcare Spending, by Payment Source, 2015-2040
Figure 8: Block Diagram of LDS Imaging System
Figure 9: Structure of Software
Figure 10: Global Deaths from Cancer, 2015 and 2030
Figure 11: Global Deaths from CVD, 2015 and 2030
Figure 12: Global CVD Deaths, by Type, 2015
Figure 13: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
Figure 14: Oral Cavity and Pharynx Cancer versus All New Cancer Cases in the U.S., 2018
Figure 15: Percentage of New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
Figure 16: Global Number of Deaths Caused by Selected Chronic Disease, 2015
Figure 17: Rising Chronic Diseases in the United States, 2000-2030
Figure 18: Top 10 Causes of Death, 2016
Figure 19: Percentage of Global Population with Cancer, 2005-2016
Figure 20: Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging
Figure 21: Factors Affecting Breast Cancer Risk in Women
Figure 22: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
Figure 23: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
Figure 24: Global Disease Burden Rates, by Cancer Type, 2016
Figure 25: Applications of Laparoscopy
Figure 26: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
Figure 27: Steps to Derive Final 3D Image through Web-based Surgical Imaging Platform
Figure 28: Major Market Drivers
Figure 29: Advantages of 3D Mammography versus 2D
Figure 30: Most Common Cancers Causing Death Globally, by Type, 2015
Figure 31: U.S. Hospitals, by Type, 2016
Figure 32: Global Prevalence of Dementia, 2015-2050
Figure 33: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
Figure 34: Major Factors Driving the Growth of Global Diagnostic Centers Market
Figure 35: Applications of 3D Medical and Surgical Imaging Platforms in Diagnostic Centers
Figure 36: Global Healthcare Expenditure, 2012 and 2015
Figure 37: Distribution of Healthcare Expenditures, by Country, 2017
Figure 38: Alzheimer’s Dementia in the United States, by Age Group, 2017
Figure 39: Chronic Diseases, 2005-2030
Figure 40: Total Healthcare Expenditure in Europe, by Category, 2018
Figure 41: Musculoskeletal Disorders in France, by Variable Type, 2016
Figure 42: French Health Spending and Financing, 2005-2015
Figure 43: Geriatric Population in Germany, 2000-2030
Figure 44: Hospitals in Germany, by Category, 2015 and 2016
Figure 45: Role of Medical Radiation Imaging in Cancer Management
Figure 46: Breast Cancer in Norway, 2014 and 2015
Figure 47: Chinese Cancer Prevalence, by Gender and Type, 2016
Figure 48: Japanese Aging Population and Future Estimates, 2010-2040
Figure 49: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
Figure 50: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
Figure 51: Projected Healthcare Spending in Argentina, 2014 and 2040
Figure 52: Industry Structure for 3D Medical and Surgical Imaging Market
Figure 53: Factors Influencing Supplier Contracts Within 3D Medical and Surgical Imaging Market
Figure 54: Medical Technology R&D Process
Figure 55: R&D from Conceptualization to Development
Figure 56: Marketing Matrix for Medical Technology Products
Figure 57: Medical and Surgical Imaging Instruments Manufacturing Process
Figure 58: Global Healthcare Expenditure, by Institutional Spending, 2015-2025
Figure 59: Block-Chain Capabilities Across Supply Chain
Figure 60: Global Logistics Robotics Market Revenue Forecast, 2015-2021
Summary Figure: Global Market for 3D Medical and Surgical Imaging Platforms, by Component, 2017-2023
Figure 1: Annual Market Revenues for Robot-Assisted, Minimally Invasive Surgery, 2015-2025
Figure 2: Annual Market Revenues from Sales of Endoscopy Devices, 2015-2024
Figure 3: Cost Breakdown: Owning Hybrid Operating Rooms, by Equipment Type
Figure 4: Cloud Computing in Medical and Surgical Imaging
Figure 5: Trends in Rising Aged Population Around the World, 2014-2022
Figure 6: Trends in Number of Deaths Due to Chronic Diseases, 2005-2020
Figure 7: Rising Trends in Healthcare Spending, by Payment Source, 2015-2040
Figure 8: Block Diagram of LDS Imaging System
Figure 9: Structure of Software
Figure 10: Global Deaths from Cancer, 2015 and 2030
Figure 11: Global Deaths from CVD, 2015 and 2030
Figure 12: Global CVD Deaths, by Type, 2015
Figure 13: Global Percentage Distribution of Population Aged above 65, by Region, 2015 and 2050
Figure 14: Oral Cavity and Pharynx Cancer versus All New Cancer Cases in the U.S., 2018
Figure 15: Percentage of New Cases of Oral Cavity and Pharynx Cancer, by Age Group 2011-2015
Figure 16: Global Number of Deaths Caused by Selected Chronic Disease, 2015
Figure 17: Rising Chronic Diseases in the United States, 2000-2030
Figure 18: Top 10 Causes of Death, 2016
Figure 19: Percentage of Global Population with Cancer, 2005-2016
Figure 20: Application of 3D Medical and Surgical Imaging Platforms in Nuclear Imaging
Figure 21: Factors Affecting Breast Cancer Risk in Women
Figure 22: Top 10 Countries with the Highest Rate of Breast Cancer in 2018
Figure 23: Incidence of Breast Cancer versus Total Cancer Incidence, 2015
Figure 24: Global Disease Burden Rates, by Cancer Type, 2016
Figure 25: Applications of Laparoscopy
Figure 26: U.S. Medical and Health Research Expenditures, by Vertical, 2015 and 2016
Figure 27: Steps to Derive Final 3D Image through Web-based Surgical Imaging Platform
Figure 28: Major Market Drivers
Figure 29: Advantages of 3D Mammography versus 2D
Figure 30: Most Common Cancers Causing Death Globally, by Type, 2015
Figure 31: U.S. Hospitals, by Type, 2016
Figure 32: Global Prevalence of Dementia, 2015-2050
Figure 33: Minimally Invasive Cosmetic Surgeries Across the Globe, 2016-2017
Figure 34: Major Factors Driving the Growth of Global Diagnostic Centers Market
Figure 35: Applications of 3D Medical and Surgical Imaging Platforms in Diagnostic Centers
Figure 36: Global Healthcare Expenditure, 2012 and 2015
Figure 37: Distribution of Healthcare Expenditures, by Country, 2017
Figure 38: Alzheimer’s Dementia in the United States, by Age Group, 2017
Figure 39: Chronic Diseases, 2005-2030
Figure 40: Total Healthcare Expenditure in Europe, by Category, 2018
Figure 41: Musculoskeletal Disorders in France, by Variable Type, 2016
Figure 42: French Health Spending and Financing, 2005-2015
Figure 43: Geriatric Population in Germany, 2000-2030
Figure 44: Hospitals in Germany, by Category, 2015 and 2016
Figure 45: Role of Medical Radiation Imaging in Cancer Management
Figure 46: Breast Cancer in Norway, 2014 and 2015
Figure 47: Chinese Cancer Prevalence, by Gender and Type, 2016
Figure 48: Japanese Aging Population and Future Estimates, 2010-2040
Figure 49: 20 Most Commonly Diagnosed Cancers in Australia (Males), 2017
Figure 50: 20 Most Commonly Diagnosed Cancers in Australia (Females), 2017
Figure 51: Projected Healthcare Spending in Argentina, 2014 and 2040
Figure 52: Industry Structure for 3D Medical and Surgical Imaging Market
Figure 53: Factors Influencing Supplier Contracts Within 3D Medical and Surgical Imaging Market
Figure 54: Medical Technology R&D Process
Figure 55: R&D from Conceptualization to Development
Figure 56: Marketing Matrix for Medical Technology Products
Figure 57: Medical and Surgical Imaging Instruments Manufacturing Process
Figure 58: Global Healthcare Expenditure, by Institutional Spending, 2015-2025
Figure 59: Block-Chain Capabilities Across Supply Chain
Figure 60: Global Logistics Robotics Market Revenue Forecast, 2015-2021
